Bronkorest Tablets deliver trusted pharmaceutical relief for symptoms of common cold, influenza, and upper respiratory infections. Each tablet contains a scientifically balanced co...

Bronkorest Tablets deliver trusted pharmaceutical relief for symptoms of common cold, influenza, and upper respiratory infections. Each tablet contains a scientifically balanced combination of Paracetamol IP (500 mg), Phenylephrine HCL (10 mg), Chlorpheniramine Maleate IP (2 mg), and Caffeine anhydrous (30 mg). This formulation effectively addresses multiple symptoms including fever, nasal congestion, allergic reactions, and fatigue. Available in both tablet and syrup forms, Bronkorest provides flexibility for different patient preferences and age groups. Manufactured under strict quality control standards, the product ensures consistent potency and reliability batch after batch. Healthcare professionals value Bronkorest for its comprehensive approach to symptom management, making it a preferred choice in both prescription and over-the-counter settings.

Bronkorest Tablets serve diverse healthcare sectors including hospitals, clinics, retail pharmacies, and institutional healthcare providers. Hospitals utilize these tablets in emergency departments and general wards for patients presenting with respiratory infections. Retail pharmacies stock Bronkorest as a reliable OTC option for customers seeking effective cold relief. Clinic physicians prescribe them for conditions like pharyngitis and tonsillitis where symptomatic relief is crucial. The syrup formulation makes it suitable for pediatric use in children's hospitals and pediatric clinics. Distributors and wholesalers supply Bronkorest to various healthcare institutions, recognizing its consistent demand across multiple medical settings and patient demographics.

The business value of Bronkorest Tablets lies in their proven reliability and market acceptance among healthcare providers. Distributors benefit from consistent demand patterns, especially during seasonal illness peaks, ensuring stable inventory turnover. The product's dual formulation allows businesses to cater to broader market segments without maintaining multiple SKUs. The established efficacy and safety profile reduces liability concerns while building trust with end-users. Manufacturers maintain strict quality assurance protocols, ensuring every batch meets pharmaceutical standards, which translates to minimal returns and customer complaints for distributors and retailers.

Key Features:
- Contains Paracetamol IP 500 mg for effective fever reduction and pain relief
- Includes Phenylephrine HCL 10 mg for nasal decongestion and improved breathing
- Formulated with Chlorpheniramine Maleate IP 2 mg to combat allergic reactions
- Enhanced with Caffeine anhydrous 30 mg to counteract drowsiness and maintain alertness
- Available in both tablet and syrup formulations for flexible dosing options

Benefits:
- Comprehensive symptom relief addressing fever, congestion, allergies, and fatigue
- Trusted formulation preferred by healthcare professionals worldwide
- Dual format availability caters to both adult and pediatric patient needs
- Consistent quality and reliability across all production batches
- Proven safety profile with minimal side effects for patient comfort